DocExpress Introduces the World’s First Sino-US Hospital Internationalization AI Platform
NEW YORK (PRWEB) May 24, 2018 -- DocExpress, a medical technology group, based in New York City, recently released its new AI medical platform—DOCX1 AI platform, which aims at connecting more than 1,000 China provincial or municipal hospitals with top US hospitals and doctors, to provide advanced international medical services to millions of Chinese cancer patients.
Leonardo Zhang, founder and CEO of DocExpress said, “Every 7 seconds, a new Chinese patient will be diagnosed as cancer, and we have 4 million new cancer patients in China every year, but the medical treatment level for cancer is not that good in China, the five-year cancer survival rate in China is only 30% comparing to 66% in the US.”
Accord to the marketing report of McKinsey, the market value of international medical service in China will exceed 50 billion dollar in future 5 years, however, only 40 China hospitals out of more than 1,000 provincial or municipal hospitals have connections with US hospitals and doctors to provide international medical services. The other 960 hospitals are eager but unable to work with top US hospitals and doctors independently due to language barriers, poor medical resources and high operation cost, however nearly 90% of Chinese cancer patients have to get long term medical treatment in these hospitals because ward beds in top-tier China hospitals are scarce.”
DOCX1 provides a good solution for China hospitals to provide international medical services, it is fast, easy to use, breaks the boundaries and language barrier, enabling China hospitals to connect and work with more than 20 top US hospitals and 1000 doctors within few clicks to provide international medical services to Chinese patients together. DOCX1 is consist of an exclusive AI medical platform and a cloud database with abundant top US hospitals and top doctors resources, which will help China hospitals improve treatment level in a long term by providing customized and comprehensive internationalization services for each China hospital, including International telemedicine program, patient referral, doctor medical visiting scholar program, China-US hospital partnership and other services.
Leonardo Zhang concluded, “DOCX1 is free for China hospitals to use, and we charge certain service fee of deals happened in our platform. In the future, DocExpress will explore the value of millions of Chinese cancer patients’ data with on our AI platform, and will connect hospitals all around the world together.
About DocExpress:
DocExpress Inc. is an international medical technology group provide AI platform for China hospital to achieve internationalization and improve medical treatment level by connecting them with top US hospitals and doctors.
For more information, please visit
http://www.docexps.com/?page_id=22903#header
Company Contact:
Leonardo Zhang, CEO / Leonardo(at)docexps.com / 201-912-4159
leonardo zhang, DOCEXPRESS INC., http://www.docexps.com/?page_id=22903#header, +1 (201) 912-4159, [email protected]
Share this article